Literature DB >> 24122186

Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid.

Anuradha Kalani, Pradip K Kamat, Srikanth Givvimani, Kasey Brown, Naira Metreveli, Suresh C Tyagi, Neetu Tyagi.   

Abstract

Epigenetic mechanisms underlying nutrition (nutrition epigenetics) are important in understanding human health. Nutritional supplements, for example folic acid, a cofactor in one-carbon metabolism, regulate epigenetic alterations and may play an important role in the maintenance of neuronal integrity. Folic acid also ameliorates hyperhomocysteinemia, which is a consequence of elevated levels of homocysteine. Hyperhomocysteinemia induces oxidative stress that may epigenetically mediate cerebrovascular remodeling and leads to neurodegeneration; however, the mechanisms behind such alterations remain unclear. Therefore, the present study was designed to observe the protective effects of folic acid against hyperhomocysteinemia-induced epigenetic and molecular alterations leading to neurotoxic cascades. To test this hypothesis, we employed 8-weeks-old male wild-type (WT) cystathionine-beta-synthase heterozygote knockout methionine-fed (CBS+/− + Met), WT, and CBS+/− + Met mice supplemented with folic acid (FA) [WT + FA and CBS+/− + Met + FA, respectively, 0.0057-μg g−1 day−1 dose in drinking water/4 weeks]. Hyperhomocysteinemia in CBS+/− + Met mouse brain was accompanied by a decrease in methylenetetrahydrofolate reductase and an increase in S-adenosylhomocysteine hydrolase expression, symptoms of oxidative stress, upregulation of DNA methyltransferases, rise in matrix metalloproteinases, a drop in the tissue inhibitors of metalloproteinases, decreased expression of tight junction proteins, increased permeability of the blood-brain barrier, neurodegeneration, and synaptotoxicity. Supplementation of folic acid to CBS+/− + Met mouse brain led to a decrease in the homocysteine level and rescued pathogenic and epigenetic alterations, showing its protective efficacy against homocysteine-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24122186      PMCID: PMC3966971          DOI: 10.1007/s12031-013-0122-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  40 in total

Review 1.  Homocysteine metabolism.

Authors:  J Selhub
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

2.  High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study.

Authors:  Katherine L Tucker; Ning Qiao; Tammy Scott; Irwin Rosenberg; Avron Spiro
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

3.  A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.

Authors:  M I Colado; E O'Shea; R Granados; A Misra; T K Murray; A R Green
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

4.  Epigenetic alterations in the brains of Fisher 344 rats induced by long-term administration of folate/methyl-deficient diet.

Authors:  Igor P Pogribny; Adam R Karpf; Smitha R James; Stepan Melnyk; Tao Han; Volodymyr P Tryndyak
Journal:  Brain Res       Date:  2008-07-30       Impact factor: 3.252

Review 5.  The role for oxidative stress in aberrant DNA methylation in Alzheimer's disease.

Authors:  Jessica L Fleming; Christopher J Phiel; Amanda Ewart Toland
Journal:  Curr Alzheimer Res       Date:  2012-11       Impact factor: 3.498

6.  Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity.

Authors:  Pradeep K Kamat; Santoshkumar Tota; Gunjan Saxena; Rakesh Shukla; Chandishwar Nath
Journal:  Brain Res       Date:  2009-10-31       Impact factor: 3.252

7.  Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions.

Authors:  Richard S Beard; Jason J Reynolds; Shawn E Bearden
Journal:  Blood       Date:  2011-06-24       Impact factor: 22.113

8.  Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.

Authors:  José Alvarez-Sabín; Pilar Delgado; Sònia Abilleira; Carlos A Molina; Juan Arenillas; Marc Ribó; Esteban Santamarina; Manolo Quintana; Jasone Monasterio; Joan Montaner
Journal:  Stroke       Date:  2004-04-15       Impact factor: 7.914

9.  Concurrent folate treatment prevents Na+,K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development.

Authors:  Cristiane Matté; Emilene B S Scherer; Francieli M Stefanello; Alethéa G Barschak; Carmen R Vargas; Carlos A Netto; Angela T S Wyse
Journal:  Int J Dev Neurosci       Date:  2007-10-07       Impact factor: 2.457

Review 10.  Murine models of hyperhomocysteinemia and their vascular phenotypes.

Authors:  Sanjana Dayal; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

View more
  39 in total

1.  Journal of molecular neuroscience: impacting our brains.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2014-11       Impact factor: 3.444

Review 2.  Environmental Deflection: The Impact of Toxicant Exposures on the Aging Epigenome.

Authors:  Joseph Kochmanski; Luke Montrose; Jaclyn M Goodrich; Dana C Dolinoy
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

3.  A possible molecular mechanism of hearing loss during cerebral ischemia in mice.

Authors:  Pradip Kumar Kamat; Anuradha Kalani; Naira Metreveli; Suresh C Tyagi; Neetu Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2015-03-11       Impact factor: 2.273

4.  Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.

Authors:  Ankur Jindal; Sathyanarayanan Rajagopal; Lucas Winter; Joshua W Miller; Donald W Jacobsen; Jonathan Brigman; Andrea M Allan; Surojit Paul; Ranjana Poddar
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

5.  Maternal Folic Acid Supplementation During Pregnancy Improves Neurobehavioral Development in Rat Offspring.

Authors:  Xinyan Wang; Wen Li; Shou Li; Jing Yan; John X Wilson; Guowei Huang
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

6.  Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury.

Authors:  Avisek Majumder; Mahavir Singh; Jyotirmaya Behera; Nicholas T Theilen; Akash K George; Neetu Tyagi; Naira Metreveli; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2018-08-15       Impact factor: 4.249

7.  Hydrogen sulfide epigenetically mitigates bone loss through OPG/RANKL regulation during hyperhomocysteinemia in mice.

Authors:  Jyotirmaya Behera; Akash K George; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Bone       Date:  2018-06-13       Impact factor: 4.398

Review 8.  Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia.

Authors:  Anuradha Kalani; Pradip K Kamat; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

9.  EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Rev Esp Escler Mult       Date:  2014-03

10.  Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.

Authors:  Anuradha Kalani; Pradip K Kamat; Anastasia Familtseva; Pankaj Chaturvedi; Nino Muradashvili; Nithya Narayanan; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.